• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人非小细胞肺癌中的蛋白表达:系统数据库。

Protein expression in human non-small cell lung cancer: a systematic database.

机构信息

Department of General, Gastrointestinal and Thoracic Surgery, Evangelic Hospital Bielefeld, DE-33617 Bielefeld, Germany.

出版信息

Pathobiology. 2009;76(6):277-85. doi: 10.1159/000245893. Epub 2009 Nov 30.

DOI:10.1159/000245893
PMID:19955839
Abstract

OBJECTIVES

The following database integrates results from published proteomics studies in human non-small cell lung cancer (NSCLC), with a focus on squamous cell cancers (SCC) and adenocarcinomas (AC).

METHODS

Only studies on NSCLC were analyzed. Results from 12 studies were available, 5 studies on SCC, 4 on AC, 1 on AC and SCC, and 2 on NSCLC without further distinction. Human cancer tissues, paired normal tissues, paired cancer patient's sera, normal sera or human tumor cell lines were analyzed. Three technologies were applied: two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), differential in-gel electrophoresis (DIGE) and serological proteome analysis (SERPA).

RESULTS

The total number of NSCLC patients was 306. Out of 261 differentially expressed proteins, 192 proteins (74%) were mentioned in a single study, 40 (15%) were mentioned by 2 different studies. 18 (7%) in 3 studies, 4 (2%) in 4 studies, 2 (1%) in 5 studies, and a single protein was listed in 6 studies.

CONCLUSION

Overlapping of protein expression is low between SCC and AC. However, a few proteins appear to be upregulated in SCC and AC: triosephosphate isomerase, protein disulfide isomerase and phosphoglycerate mutase (phosphoglycerate kinase 1). These three proteins might be key players in human lung cancer.

摘要

目的

本数据库整合了已发表的人类非小细胞肺癌(NSCLC)蛋白质组学研究结果,重点关注鳞状细胞癌(SCC)和腺癌(AC)。

方法

仅分析 NSCLC 相关研究。共有 12 项研究的结果可用,其中 5 项研究针对 SCC,4 项研究针对 AC,1 项研究同时针对 SCC 和 AC,还有 2 项研究针对 NSCLC 但未进一步细分。研究分析了人类癌症组织、配对正常组织、配对癌症患者血清、正常血清或人类肿瘤细胞系。应用了三种技术:二维聚丙烯酰胺凝胶电泳(2D-PAGE)、差异凝胶电泳(DIGE)和血清蛋白质组分析(SERPA)。

结果

共有 306 例 NSCLC 患者。在 261 个差异表达蛋白中,192 个蛋白(74%)仅在一项研究中被提及,40 个蛋白(15%)被两项不同的研究提及。18 个蛋白(7%)被三项研究提及,4 个蛋白(2%)被四项研究提及,2 个蛋白(1%)被五项研究提及,6 项研究中各有一个蛋白被提及。

结论

SCC 和 AC 之间的蛋白表达重叠较低。然而,有一些蛋白似乎在 SCC 和 AC 中上调:磷酸丙糖异构酶、蛋白二硫键异构酶和磷酸甘油酸变位酶(磷酸甘油酸激酶 1)。这三种蛋白可能是人类肺癌的关键参与者。

相似文献

1
Protein expression in human non-small cell lung cancer: a systematic database.人非小细胞肺癌中的蛋白表达:系统数据库。
Pathobiology. 2009;76(6):277-85. doi: 10.1159/000245893. Epub 2009 Nov 30.
2
Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain.与肺鳞状细胞癌脑转移相关的S100A7的鉴定与验证
Lung Cancer. 2007 Jul;57(1):37-45. doi: 10.1016/j.lungcan.2007.02.020. Epub 2007 Apr 5.
3
HMGA2 overexpression in non-small cell lung cancer.高迁移率族蛋白A2(HMGA2)在非小细胞肺癌中的过表达
Mol Carcinog. 2007 Jul;46(7):503-11. doi: 10.1002/mc.20235.
4
Expression of cell proliferating genes in patients with non-small cell lung cancer by immunohistochemistry and cDNA profiling.通过免疫组织化学和cDNA分析检测非小细胞肺癌患者细胞增殖基因的表达
Oncol Rep. 2005 May;13(5):837-46.
5
Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma.甲状腺转录因子-1在原发性、可切除非小细胞肺癌中的预后价值
Mod Pathol. 1999 Mar;12(3):318-24.
6
Reduced transcription of the RB2/p130 gene in human lung cancer.人类肺癌中RB2/p130基因转录减少。
Mol Carcinog. 2003 Nov;38(3):124-9. doi: 10.1002/mc.10152.
7
Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance.非小细胞肺癌中HIC-1基因表达降低及其临床意义
Anticancer Res. 2001 Jan-Feb;21(1B):535-40.
8
Caveolins as tumour markers in lung cancer detected by combined use of cDNA and tissue microarrays.通过联合使用cDNA和组织微阵列检测小窝蛋白作为肺癌的肿瘤标志物
J Pathol. 2004 May;203(1):584-93. doi: 10.1002/path.1552.
9
Proteome analysis of human lung squamous carcinoma.人肺鳞状细胞癌的蛋白质组分析
Proteomics. 2006 Jan;6(2):547-58. doi: 10.1002/pmic.200500256.
10
Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?肺腺鳞癌是腺癌和鳞癌的简单混合,还是在分子水平上更复杂?
Lung Cancer. 2010 Apr;68(1):1-9. doi: 10.1016/j.lungcan.2009.11.001. Epub 2009 Dec 8.

引用本文的文献

1
Discovery of rafoxanide as a novel agent for the treatment of non-small cell lung cancer.发现雷氟拉嗪可作为一种新型药物用于治疗非小细胞肺癌。
Sci Rep. 2023 Jan 13;13(1):693. doi: 10.1038/s41598-023-27403-y.
2
A MicroRNA Exerts Antitumor Effects Through Inhibition of Both Cell Migration and Angiogenesis by Targeting PGAM1.一种微小RNA通过靶向PGAM1抑制细胞迁移和血管生成发挥抗肿瘤作用。
Front Oncol. 2021 Jun 16;11:652395. doi: 10.3389/fonc.2021.652395. eCollection 2021.
3
Drug Screening Analysis against the Overexpression of Gene in Different Cancer Treatments.
针对不同癌症治疗中基因过表达的药物筛选分析。
Biomed Res Int. 2021 May 31;2021:5515692. doi: 10.1155/2021/5515692. eCollection 2021.
4
Downregulation of circRNA_100876 Inhibited Progression of NSCLC In Vitro via Targeting miR-636.环状 RNA_100876 通过靶向 miR-636 抑制 NSCLC 的体外进展。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820951817. doi: 10.1177/1533033820951817.
5
Phosphoglycerate Mutase 1: Its Glycolytic and Non-Glycolytic Roles in Tumor Malignant Behaviors and Potential Therapeutic Significance.磷酸甘油酸变位酶1:其在肿瘤恶性行为中的糖酵解和非糖酵解作用及潜在治疗意义
Onco Targets Ther. 2020 Feb 27;13:1787-1795. doi: 10.2147/OTT.S238920. eCollection 2020.
6
Energy Metabolism in Cancer: The Roles of STAT3 and STAT5 in the Regulation of Metabolism-Related Genes.癌症中的能量代谢:STAT3和STAT5在代谢相关基因调控中的作用
Cancers (Basel). 2020 Jan 3;12(1):124. doi: 10.3390/cancers12010124.
7
PGAM1 knockdown is associated with busulfan‑induced hypospermatogenesis and spermatogenic cell apoptosis.PGAM1 敲低与白消安诱导的精子发生减少和生精细胞凋亡有关。
Mol Med Rep. 2019 Apr;19(4):2497-2502. doi: 10.3892/mmr.2019.9930. Epub 2019 Feb 4.
8
Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.磷酸甘油酸变位酶 1(PGAM1)通过作为 PI3K/Akt/mTOR 通路的新型下游靶标促进胰腺导管腺癌(PDAC)转移。
Oncol Res. 2018 Aug 23;26(7):1123-1131. doi: 10.3727/096504018X15166223632406. Epub 2018 Jan 31.
9
Phosphoglycerate mutase 1 knockdown inhibits prostate cancer cell growth, migration, and invasion.磷酸甘油酸变位酶1基因敲低抑制前列腺癌细胞的生长、迁移和侵袭。
Asian J Androl. 2018 Mar-Apr;20(2):178-183. doi: 10.4103/aja.aja_57_17.
10
Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy.现行世卫组织指南与免疫组织化学标志物在非小细胞肺癌(NSCLC)分类中的关键作用:从靶向治疗到免疫治疗。
Semin Cancer Biol. 2018 Oct;52(Pt 1):103-109. doi: 10.1016/j.semcancer.2017.11.019. Epub 2017 Nov 26.